Edward J. Sitar - Dec 15, 2022 Form 4 Insider Report for Timber Pharmaceuticals, Inc. (TMBR)

Role
Director
Signature
/s/ Joseph Lucchese, Power of Attorney
Stock symbol
TMBR
Transactions as of
Dec 15, 2022
Transactions value $
$4,073
Form type
4
Date filed
12/16/2022, 03:05 PM
Previous filing
Apr 19, 2022
Next filing
Apr 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMBR Common Stock, par value $0.001 per share Award $4.07K +2.5K +75.76% $1.63 5.8K Dec 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 750 restricted stock units that are unvested.

Remarks:

The shares reported on this Form 4 have been adjusted to reflect the Issuer's 1-for-50 reverse stock split of its common stock, effective November 8, 2022.